Skip to content
2000
Volume 21, Issue 13
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Coronavirus spreads from one to another person, either by touching the hands or by touching the surface contaminated with this virus, and then touching the nose or mouth. COVID-19 infected human symptoms are like pneumonia symptoms, dry cough and high fever. Upper respiratory tract infections symptoms and sore throat are rare. It was first notified in China dated 12th December 2019 as a respiratory illness. In addition to travel restrictions and quarantine measures, everyone should follow the World Health Organization's advice guidelines on the management of humans infected with known or suspected infection with the SARS-CoV-2 virus at the personal level. The development of vaccine or medicines for the same is in progress and this short review will summarize the most potential candidates such as Remdesivir, Lopinavir and Ritonavir, Chloroquine, Hydroxychloroquine, Hydroxychloroquine with Azithromycin, Favipiravir, Umifenovir, and Ribavirin for its medicinal treatment.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557521666201217145333
2021-08-01
2025-07-04
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557521666201217145333
Loading

  • Article Type:
    Review Article
Keyword(s): COVID-19; pneumonia; SARS-CoV-2; URI; WHO
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test